节点文献

中国胃癌肝转移患者临床诊疗特征及预后分析:全国多中心队列研究(RECORD研究)(英文)

Clinical landscape and prognosis of patients with gastric cancer liver metastases: A nation-wide multicenter cohort study in China(RECORD study)

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 高云鹤郗洪庆商亮唐兆庆卫勃乔治唐云王鑫鑫周静汪学非黄昌明陆俊李国新余江梁延锐季加孚李子禹薛侃梁寒柯彬臧潞何子锐谢少华黄华徐泽宽田艳涛熊建平李佶阳崔秋霞李力卢婷婷宋奇嬴刘诗贺孙益红李乐平陈凛RECORD研究协作组

【Author】 Yunhe Gao;Hongqing Xi;Liang Shang;Zhaoqing Tang;Bo Wei;Zhi Qiao;Yun Tang;Xinxin Wang;Jing Zhou;Xuefei Wang;Changming Huang;Jun Lu;Guoxin Li;Jiang Yu;Yanrui Liang;Jiafu Ji;Ziyu Li;Kan Xue;Han Liang;Bin Ke;Lu Zang;Zirui He;Shaohua Xie;Hua Huang;Zekuan Xu;Yantao Tian;Jianping Xiong;Jiyang Li;Qiuxia Cui;Li Li;Tingting Lu;Qiying Song;Shihe Liu;Yihong Sun;Leping Li;Lin Chen;RECORD study group;Section of Gastric Surgery, Senior Department of General Surgery, The First Medical Center, Chinese PLA General Hospital;Section of Abdominal Trauma Surgery, Senior Department of General Surgery, The First Medical Center, Chinese PLA General Hospital;Institute of General Surgery, The First Medical Center, Chinese PLA General Hospital;Department of Gastrointestinal Surgery, Shandong Provincial Hospital Affiliated to Shandong First Medical University;Department of General Surgery, Fudan University Zhongshan Hospital;Department of General Surgery, Fujian Medical University Union Hospital;Department of General Surgery, Nanfang Hospital Affiliated to Southern Medical University;Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Gastrointestinal Cancer Center, Peking University Cancer Hospital & Institute;Department of Gastric Cancer Surgery, Tianjin Medical University Cancer Institute and Hospital;Department of General Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine;Institute of Population Medicine and School of Public Health, Fujian Medical University;Department of Gastric Surgery, Fudan University Shanghai Cancer Center;Department of General Surgery, Jiangsu Province Hospital, Nanjing Medical University;Department of Pancreatic and Gastric Surgery, National Cancer Center, National Clinical Research Center for Cancer, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College;

【通讯作者】 孙益红;李乐平;陈凛;

【机构】 Section of Gastric Surgery, Senior Department of General Surgery, The First Medical Center, Chinese PLA General HospitalSection of Abdominal Trauma Surgery, Senior Department of General Surgery, The First Medical Center, Chinese PLA General HospitalInstitute of General Surgery, The First Medical Center, Chinese PLA General HospitalDepartment of Gastrointestinal Surgery, Shandong Provincial Hospital Affiliated to Shandong First Medical UniversityDepartment of General Surgery, Fudan University Zhongshan HospitalDepartment of General Surgery, Fujian Medical University Union HospitalDepartment of General Surgery, Nanfang Hospital Affiliated to Southern Medical UniversityKey Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Gastrointestinal Cancer Center, Peking University Cancer Hospital & InstituteDepartment of Gastric Cancer Surgery, Tianjin Medical University Cancer Institute and HospitalDepartment of General Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of MedicineInstitute of Population Medicine and School of Public Health, Fujian Medical UniversityDepartment of Gastric Surgery, Fudan University Shanghai Cancer CenterDepartment of General Surgery, Jiangsu Province Hospital, Nanjing Medical UniversityDepartment of Pancreatic and Gastric Surgery, National Cancer Center, National Clinical Research Center for Cancer, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College

【摘要】 <正>Despite surgical improvements and pharmacological advances,management of late-stage gastric cancer patients,especially those with hepatic metastasis remains challenging [1-3].Although nationwide registry data from SEER (Surveillance,Epidemiology,and End Results)[4] and the Nordic database [5] in Western countries have provided epidemiological information for patients with gastric cancer liver metastasis (GCLM),little is known about the detailed clinical characteristics.Recently,emerging evidence has indicated that selective implementation of systemic chemotherapy,immune checkpoint inhibitor (ICI) therapy,surgical resection,

【基金】 supported by the National Natural Science Foundation of China (81972790);the Beijing Nova Program(Z181100006218011)
  • 【文献出处】 Science Bulletin ,科学通报(英文) , 编辑部邮箱 ,2024年03期
  • 【分类号】R735.2
  • 【下载频次】16
节点文献中: 

本文链接的文献网络图示:

本文的引文网络